Beta Bionics price to sales ratio BBNX
Market value divided by revenue over the last twelve months, since 2025.
- Today, Nov 2, 2026
- 6.8×
- Peer median
- 1.9×
Beta Bionics' price to sales ratio is 6.8× as of Nov 2, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 1.9×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 6.8× | 3.8× | 14.5× |
| 2025 | 15.8× | 13.1× | 15.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Beta Bionics' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| BBNXBeta Bionics | 6.8× |
| IRMDIradimed | 11.4× |
| MOVMovado | 1.0× |
| IARTIntegra Lifesciences | 0.6× |
| BVSBioventus | 1.9× |
| STAAStaar Surgical | 3.7× |
| CDRECadre | 2.0× |
| EYENational Vision | 0.7× |
| TCMDTactile Systems Technology | 1.5× |
| LMATLemaitre Vascular | 7.1× |
| INSPInspire Medical Systems | 2.2× |
| Peer median | 1.9× |
Where Beta Bionics ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Beta Bionics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.